Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Acquire Euroscreen Products in Bid to Fatten GPCR Play

NEW YORK (GenomeWeb News) — PerkinElmer today said it plans to acquire privately held GPCR company Euroscreen Products for an undisclosed amount.
Euroscreen Products provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
PerkinElmer CEO Gregory Summe said the acquisition is the company’s “next step in our strategy to build the most comprehensive offering in cellular and drug discovery reagent technologies.”
By marketing Euroscreen Products’ AequoScreen platform in particular, Summe added, PerkinElmer would be able to offer its customers a “GPCR screening solution that improves performance and reduces workflow costs, while dramatically increasing lab productivity.”
PerkinElmer expects the acquisition to close some time during the first quarter of 2007.
Earlier this month PerkinElmer announced its plans to acquire high-throughput screening company Evotec Technologies for €23 million ($30.5 million) in cash.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.